{
    "clinical_study": {
        "@rank": "107781", 
        "brief_summary": {
            "textblock": "It is proposed that patients with skin disease due to presumed immunologic, genetic or\n      viral-induced abnormalities, patients with neurological degenerations,  and normal controls\n      be evaluated with various in vitro studies of immunologic, genetic, and virologic function.\n      This is to include studies of peripheral blood (cells and serum) as well as studies of skin\n      obtained with a biopsy instrument.  In addition, studies of gastrointestinal function will\n      be performed where appropriate."
        }, 
        "brief_title": "Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers", 
        "completion_date": "June 2000", 
        "condition": [
            "Healthy", 
            "Muscular Dystrophy", 
            "Retinal Degeneration", 
            "Skin Diseases", 
            "Virus Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Muscular Dystrophies", 
                "Retinal Degeneration", 
                "Skin Diseases", 
                "Virus Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "It is proposed that patients with skin disease due to presumed immunologic, genetic or\n      viral-induced abnormalities, patients with neurological degenerations,  and normal controls\n      be evaluated with various in vitro studies of immunologic, genetic, and virologic function.\n      This is to include studies of peripheral blood (cells and serum) as well as studies of skin\n      obtained with a biopsy instrument.  In addition, studies of gastrointestinal function will\n      be performed where appropriate."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Patients with skin diseases of presumed genetic, immunologic, or virologic origin are\n        eligible.\n\n        Patients with neurological degenerations are eligible, including patients with\n        inflammatory, neoplastic and viral skin diseases and also heterozygous carriers of such\n        inherited diseases.\n\n        Volunteers without skin diseases are eligible, except children."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001164", 
            "org_study_id": "780099", 
            "secondary_id": "78-C-0099"
        }, 
        "keyword": [
            "Genetic Evaluation", 
            "Immunologic Evaluations", 
            "Inflammatory Skin Disease", 
            "Muscular Dystrophies", 
            "Neoplastic Skin Diseases", 
            "Neuronal Degenerations", 
            "Retinal Degenerations", 
            "Viral Diseases"
        ], 
        "lastchanged_date": "March 4, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Cancer Institute (NCI)"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "164028", 
                "citation": "Kraemer KH, Coon HG, Petinga RA, Barrett SF, Rahe AE, Robbins JH. Genetic heterogeneity in xeroderma pigmentosum: complementation groups and their relationship to DNA repair rates. Proc Natl Acad Sci U S A. 1975 Jan;72(1):59-63."
            }, 
            {
                "PMID": "972257", 
                "citation": "Yaoita H, Katz SI. Immunoelectronmicroscopic localization of IgA in skin of patients with dermatitis herpetiformis. J Invest Dermatol. 1976 Oct;67(4):502-6."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001164"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "July 1978", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "June 2000"
    }, 
    "geocoordinates": {
        "National Cancer Institute (NCI)": "38.985 -77.095"
    }
}